Endovia Health Sciences, Inc.

Endovia Health Sciences, Inc.

AAMEX:EDVA
0.17
USD
-0.01
(-6.56%)
-11.88EPS
10.02MMarket Cap
Nov 18Next Earn

Total Valuation

USD

As of June 30, 2026, Endovia Health Sciences, Inc. carries a market capitalization of 10.02M, placing it among publicly traded companies globally. Its enterprise value stands at 16.16M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap10.02M
Enterprise Value16.16M

Important Dates

Endovia Health Sciences, Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

Earnings Date11/18/2026

Share Statistics

As of June 30, 2026, Endovia Health Sciences, Inc. has 4.04M shares outstanding.

Shares Outstanding4.04M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is -9.45, and the price-to-book ratio stands at -0.64.

PS Ratio-9.45
PB Ratio-0.64
P/TBV Ratio-0.64
P/FCF Ratio-0.63
P/OCF Ratio-0.63

Financial Position

As of June 30, 2026, Endovia Health Sciences, Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -40.55, indicating conservative leverage, while an interest coverage ratio of -5.19 demonstrates limited ability to service its debt obligations.

Current Ratio0.05
Quick Ratio0.02
Debt / Equity-40.55
Debt / EBITDA-0.47
Interest Coverage-5.19

Financial Efficiency

USD

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -148.26, reflecting losses generated across the asset base. The company generates approximately -53,478.81 in revenue per employee across its workforce of 6.75, a quick read on workforce productivity versus industry peers. Inventory turnover of -0.90 indicates how many times Endovia Health Sciences, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-148.26
Revenue Per Employee-53,478.81
Employee Count6.75
Inventory Turnover-0.90

Stock Price Statistics

USD

As of the close on November 16, 2026, Endovia Health Sciences, Inc.'s stock has declined approximately 99.01% over the past 52 weeks. The 50-day moving average sits at 0.18, while the 200-day moving average is 3.50.

52-Week Price Change-99.01%
50-Day Moving Average0.18
200-Day Moving Average3.50

Income Statement

USD

Over the twelve months ended June 30, 2026, Endovia Health Sciences, Inc. generated -360,982.00 in revenue and converted that into -17.28M in net income, yielding earnings per share of -11.88. EBITDA reached -13.50M, while operating income came in at -13.51M.

Revenue-360,982.00
Gross Profit49,189.00
Operating Income-13.51M
Pretax Income-16.35M
Net Income-17.28M
EBITDA-13.50M
EBIT-13.51M
Earnings Per Share (EPS)-11.88

Balance Sheet

USD

As of June 30, 2026, Endovia Health Sciences, Inc. holds 242,702.00 in cash and equivalents against 6.39M in total debt, resulting in a net debt position of 6.14M. Total book value stands at -15.75M, with working capital of -15.92M providing operational flexibility.

Cash & Cash Equivalents242,702.00
Total Debt6.39M
Net Debt6.14M
Equity (Book Value)-15.75M
Book Value Per Share-3.90
Working Capital-15.92M

Cash Flow

USD

Endovia Health Sciences, Inc. produced -5.45M in operating cash flow over the twelve months ended June 30, 2026.

Operating Cash Flow-5.45M
Free Cash Flow-5.45M
FCF Per Share-3.96

Margins

Over the twelve months ended June 30, 2026, Endovia Health Sciences, Inc. posted a gross margin of -13.63, reflecting its pricing power and cost economics. The operating margin of 3,741.86 and net profit margin of 4,787.65 provide insight into operational efficiency.

Gross Margin-13.63
Operating Margin3,741.86
Pretax Margin4,529.48
Profit Margin4,787.65
EBITDA Margin3,739.93

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. The dividend payout ratio of 2.25 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -159.75: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -58.51, meaning Endovia Health Sciences, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Payout Ratio2.25
Shareholder Yield-58.51
FCF Yield-159.75

Stock Splits

Endovia Health Sciences, Inc.'s most recent stock split took place on July 27, 2026 with a 4:1 split ratio.

Last Split Date7/27/2026
Split Ratio4:1

Scores

As of June 30, 2026, Endovia Health Sciences, Inc. has an Altman Z-Score of -302.16, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-302.16